In this episode of BioTalk with Rich Bendis, Matt Adams, Chief Executive Officer of BrainScope, joins the conversation to discuss how the Rockville-based company is working to bring objective brain function measurement into real-world clinical care.
Matt shares how BrainScope is using EEG-based technology and artificial intelligence to help decode brain electrical activity and provide clinicians, patients, and care teams with simple, actionable information. He explains why objective data is especially important in brain health, where many assessments can still be subjective, difficult to scale, or dependent on more expensive infrastructure.
Listen via your favorite podcast platform:
Apple: https://apple.co/45FA0RX
Spotify: https://bit.ly/3Sbowm5
iHeart Podcasts: https://ihr.fm/4qBHsqX
Amazon Podcasts: https://amzn.to/4qvM95m
YouTube Podcasts (Audio): https://bit.ly/4gpBEgN
TuneIn: https://bit.ly/4xnE2L0
The conversation also looks at BrainScope’s evolution since winning the BioHealth Capital Region Crab Trap Competition in 2020. Matt discusses how the company has moved from a point-of-care EEG technology focused on traumatic brain injury into a broader AI-enabled brain health platform with potential applications across concussion, brain bleeds, dementia, Alzheimer’s disease, and other neurological conditions.
Rich and Matt also discuss BrainScope’s FDA-cleared technology, its growing clinical and regulatory foundation, and how the company is using machine learning, deep learning, and a large EEG database to expand what can be measured in brain health. Matt highlights the company’s work in Alzheimer’s prediction, including data suggesting the potential to identify risk years before typical clinical diagnosis, as well as the opportunity to support longitudinal monitoring and improved CNS trial design.
The episode also looks ahead to BrainScope’s next phase, including expanded disease applications, partnerships with clinicians and sports medicine organizations, potential use in clinical trials, global market opportunities, and the company’s continued growth in the BioHealth Capital Region.
Editing and post-production work for this episode was provided by The Podcast Consultant.
Matt Adams brings more than 25 years of global healthcare leadership experience developing, commercializing, and scaling medical device, biotechnology, diagnostic product, and service businesses. He currently serves as Chief Executive Officer of BrainScope, a tech-enabled AI software platform focused on brain health. Before joining BrainScope, Matt was President of Invio Automation, a global life science-focused process automation provider. He previously served as Vice President and General Manager of Cerevention, a neuro startup that developed and commercialized platforms to diagnose and treat hemorrhagic stroke and other diseases of the central nervous system. He has also held executive roles at Rebiotix, Cirle, and American Medical Systems. Matt received his eMBA from the University of Minnesota, a Master of Science in Biomedical Engineering from the University of Minnesota, and a Bachelor of Science in Mechanical Engineering from the University of Alaska.